Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2002 > Volume 11 Number 4 July 2002 > DEVICE EVALUATION > Long-Term Outcome after Valve replacement with the Omnicarbon Prosthesis

Long-Term Outcome after Valve replacement with the Omnicarbon Prosthesis

Michele di Summa MD, Giuseppe Poletti MD, Lidia Brero MD, Paolo Centofanti MD, Michele La Torre MD, Francesco Patanè MD, Jose M. Caffarena Raggio MD, Francisco García Sanchez MD, Jose M. Maroñas MD, Salvador Torregrosa MD, Francisco J. Valera MD, Jose Caffarena, Jr. MD

Intensive long-term follow up of 153 Omnicarbon valve patients accumulated 1,472 patient-years (mean follow up per patient 10.2 ± 4.4 years). Among patients, 51% (n = 78) had aortic valve replacement, 33% (n = 51) mitral valve replacement, and 16% (n = 24) both aortic and mitral valve replacement. Follow up was 99% complete (n = 151). Ten-year survival was 68 ± 4% overall, and freedom from thromboembolism 94 ± 2% and 91 ± 3%

at 10 and 14 years, respectively. The median INR was 2.8 for aortic and mitral valve patients at 14 years after surgery. Acceptable long-term hemodynamics, NYHA functional class and hemolytic indicator values were obtained. Low complication rates were observed, and the patients¹ long-term overall quality of life exceeded expectation.

Long-Term Outcome after Valve replacement with the Omnicarbon Prosthesis

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

This article doesn't appear to be availble for purchase as a single artilce. Please contact us for further information.